UUÂãÁÄÖ±²¥

Introduction

Benefits to Attending...

400+ attendees and 30+ presentations

Explore how companies are furthering their understanding of the tumour microenvironment through the latest technologies, including spatial imaging and novel biomarkers

Gain insights in emerging therapeutic opportunities through targeting the tumour microenvironment with immuno-oncology

Learn about recent advances in tumour microenvironment research at the basic, translational and clinical application levels

Useful links

Speakers

• David Gilham Celyad, United Kingdom
• Pelin Candarlioglu GlaxoSmithKline, United Kingdom
• Klaus Dembowsky amcure, United Kingdom
• Peter Ellmark Allgiator Bio, United Kingdom
• Philip Bland-ward Crescendo BIologics, United Kingdom
• Jens Kringelum Evaxion, United Kingdom

---

Organised by

Oxford Global

Contact information

Bronwyn Westmore
Oxford Global
Contact us by email

---